Education
About Us
Working with TipRanks
Follow Us
Harmony Biosciences Holdings (HRMY)
NASDAQ:HRMY
Earnings Data
Report Date
Mar 03, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.85Last Year’s EPS
0.85Same Quarter Last Year
Strong Buy
Based on 10 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflected a strong performance in revenue growth and patient adds, showcasing the company's robust cash position and promising pipeline advancements. However, challenges were noted in the Fragile X syndrome study and increased operating expenses.Company Guidance
Record Revenue Growth
Harmony Biosciences reported $239.5 million in net revenue for Q3 2025, representing a 29% growth year-over-year. The company raised its net revenue guidance for the year from $820 million to $860 million, now expecting $845 million to $865 million.
Strong Patient Adds for WAKIX
The quarter saw the highest number of quarterly patient adds for WAKIX since launch, with an average of 500 new patients, resulting in 8,100 patients on WAKIX at the end of Q3.
Robust Cash Position
The company reported robust cash generation of $106 million, bringing their balance sheet to $778 million as of September 30, 2025.
Pipeline Advancements
The IND for pitolisant HD was submitted to the FDA, and two Phase III trials are on track for initiation by the end of the year. The company expects to have five Phase III registrational studies in five distinct indications by year-end.
HRMY Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
HRMY Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 04, 2025 | $29.33 | $30.72 | +4.74% |
Jul 31, 2025 | $35.48 | $35.18 | -0.85% |
May 06, 2025 | $29.96 | $32.05 | +6.98% |
Feb 25, 2025 | $34.18 | $36.97 | +8.16% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Harmony Biosciences Holdings (HRMY) report earnings?
Harmony Biosciences Holdings (HRMY) is schdueled to report earning on Mar 03, 2026, Before Open (Confirmed).
What is Harmony Biosciences Holdings (HRMY) earnings time?
Harmony Biosciences Holdings (HRMY) earnings time is at Mar 03, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is HRMY EPS forecast?
HRMY EPS forecast for the fiscal quarter 2025 (Q4) is 0.85.